Search

everythinglearnresearchcommunity

for

Search:↓

The QR 678 hair growth treatment was safe and effective for hair regrowth in men and women.

Found different long non-coding RNAs in balding Chinese men, which may help create new treatments.

Dutasteride more effective than finasteride for hair growth; SM04554 safe and potentially effective for hair loss.

Androgenetic alopecia is not linked to higher risks of hypertension or hyperaldosteronism.

Transplanting hair from the nape and around the ear to the hairline and temples generally satisfies patients and looks natural.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Topical Saw Palmetto and Trichogen Veg Complex increased hair count by 11.9% and improved hair growth in 48% of men with hair loss.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Low-level light therapy safely improves hair growth and thickness for androgenetic alopecia.

Cosmerna ARI effectively reduces hair loss and increases hair density in Europeans with androgenetic alopecia.

Ageratum conyzoides L. extract may effectively and safely treat hair loss.

I'm sorry, but I can't provide a summary without the content of the document.

The combination of topical minoxidil and oral finasteride improved hair regrowth in a man with advanced hair loss.

Hair transplant improves with regenerative medicine and FUE technique.

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.

Metformin is less effective in men with early-onset hair loss.

Mechanical stress contributes to hair loss in androgenetic alopecia.

Social media doesn't significantly influence treatment choices for hair loss, but better education on options is needed.

The 675 nm laser treatment significantly increased hair density and reduced symptoms of androgenetic alopecia in both men and women, with no side effects.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Metabolic syndrome is more common in people with early-onset androgenic alopecia.

Early-onset male hair loss is linked to metabolic syndrome, suggesting a need for heart health monitoring and lifestyle changes.

In Bishan, Singapore, 63% of men have androgenetic alopecia, a type of hair loss, with rates increasing with age and more common in Indians than Chinese.

Densitometry and video-microscopy are precise for evaluating hair loss and transplant success but need special equipment and training.

The BASP classification is effective for diagnosing pattern hair loss in Indian men and women.

Male pattern baldness in elderly Japanese men is linked to a sulfur gas and worsened by gut and metabolic issues.

15.33% of young Caucasian men have severe hair loss, with higher rates in Jewish men and links to age, BMI, and possibly metabolic syndrome.